Literature DB >> 1997415

Subclass and molecular form of immunoglobulin A antibodies to Actinobacillus actinomycetemcomitans in juvenile periodontitis.

T A Brown1, L Byres, M Gardner, T E Van Dyke.   

Abstract

Patients with juvenile periodontitis frequently have elevated levels of serum immunoglobulin A (IgA) antibodies to antigens of Actinobacillus actinomycetemcomitans. IgA occurs in two subclasses, IgA1 and IgA2, and in monomeric and polymeric forms. Because IgA1 is susceptible to cleavage by IgA1 proteases produced by microorganisms found at mucosal sites and in the gingival crevice, we wished to determine the IgA subclass distribution of antibodies to antigens of A. actinomycetemcomitans. The molecular form was examined because it may indicate the origin of the IgA and because the form differs in acute and chronic infections. There is also evidence that monomeric and polymeric IgA have different biological functions. Serum was taken from patients with juvenile periodontitis before and at intervals during and after initiation of therapy. IgA subclass distribution was determined against a sonic extracts of A. actinomycetemcomitans ATCC 2952a (serotype b) by using monoclonal anti-subclass reagents in an enzyme-linked immunosorbent assay. To determine the molecular form of the antibodies, sera were separated by high-performance liquid chromatography on a size-exclusion column. Fractions were assayed for antibody activity by the enzyme-linked immunosorbent assay, and described above. The results of the subclass analysis of the sera indicated that while both IgA1 and IgA2 antibodies to A. actinomycetemcomitans sonic extract are often found before, during, and after treatment, IgA1 antibodies dominated the response. There was a predominance of monomeric IgA1 antibodies to A. actinomycetemcomitans sonic extracts in most samples before, during, and after treatment. The monomeric form is consistent with what is seen in other chronic infections. The predominance of IgA1 antibodies implies that any protective effects of the IgA response to A. actinomycetemcomitans could be compromised by microbial IgA1 proteases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997415      PMCID: PMC258377          DOI: 10.1128/iai.59.3.1126-1130.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  The human IgA system: a reassessment.

Authors:  J Mestecky; M W Russell; S Jackson; T A Brown
Journal:  Clin Immunol Immunopathol       Date:  1986-07

2.  Molecular form and subclass distribution of IgA antibodies after immunization with live and inactivated influenza A vaccines.

Authors:  T A Brown; M L Clements; B R Murphy; J Radl; J J Haaijman; J Mestecky
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

3.  IgA subclass responses to lipopolysaccharide in humans.

Authors:  Z Moldoveanu; T A Brown; M T Ventura; S M Michalek; J R McGhee; J Mestecky
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

4.  A polymeric IgA response in serum can be produced by parenteral immunization.

Authors:  F Mascart-Lemone; J Duchateau; M E Conley; D L Delacroix
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

Review 5.  Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response.

Authors:  J Mestecky; J R McGhee
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

6.  Clinical significance of immunoglobulin A antibody to hepatitis B core antigen of polymeric and monomeric forms in chronic type B liver disease with acute exacerbation.

Authors:  M Nomura; M Douchin; A Tokuda; F Sato; S Ito; Y Kohli; N Fujiki
Journal:  Am J Gastroenterol       Date:  1988-12       Impact factor: 10.864

7.  Polymeric and monomeric IgA response in serum and milk after parenteral cholera and oral typhoid vaccination.

Authors:  F Mascart-Lemone; B Carlsson; F Jalil; M Hahn-Zoric; J Duchateau; L A Hanson
Journal:  Scand J Immunol       Date:  1988-10       Impact factor: 3.487

8.  Virus-specific polymeric immunoglobulin A antibodies in serum from patients with rubella, measles, varicella, and herpes zoster virus infections.

Authors:  A Negro Ponzi; C Merlino; A Angeretti; R Penna
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

9.  Mechanisms of neutralization of influenza virus on mouse tracheal epithelial cells by mouse monoclonal polymeric IgA and polyclonal IgM directed against the viral haemagglutinin.

Authors:  M C Outlaw; N J Dimmock
Journal:  J Gen Virol       Date:  1990-01       Impact factor: 3.891

10.  Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans.

Authors:  T A Brown; B R Murphy; J Radl; J J Haaijman; J Mestecky
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

View more
  2 in total

1.  Avidity of antibody responses to Actinobacillus actinomycetemcomitans in periodontitis.

Authors:  D S O'Dell; J L Ebersole
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

2.  Immunoglobulin class and subclass distribution of antibodies reactive with the immunodominant antigen of Actinobacillus actinomycetemcomitans serotype b.

Authors:  H Lu; J V Califano; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.